BRIEF-EMA's CHMP Recommends Marketing Authorisation Grant For Bimervax

March 30 (Reuters) -

* EMA: EMA'S CHMP RECOMMENDED GRANTING A MARKETING AUTHORISATION FOR BIMERVAX (PREVIOUSLY COVID-19 VACCINE HIPRA): 30/03/2023 Source text for Eikon: Further company coverage: [ ]